S2 Ep75: Recapping the AAN 2026 Annual Meeting: Neurologic Disease Treatment Is Rapidly Evolving
This inaugural episode of Mind the Meds introduces neurology pharmacy practice through a discussion between 3 neurology pharmacists working across inpatient and outpatient settings at the University o...
7 Touko 1h 7min
S2 Ep74: Sacituzumab Govitecan and the New Standard of Care- What the NCCN Update Means for First-Line Metastatic TNBC
1 Touko 20min
S2 Ep73: Introducing the Mind the Meds Podcast
27 Huhti 5min
S2 Ep72: APhA Preview - Dr. JAM Highlights Strategies for RSV Prevention in Adults
Dr. JAM can be found on LinkedIn.Stay tuned for Pharmacy Times' coverage of APhA 2026 in LA. It can all be found here.
26 Maalis 31min
S2 Ep71: From Global Insights to the Aisle: Practical OTC Allergy Tips for Pharmacists
You can find more information about Derek Webb, PharmD, and Dennis Williams, PharmD, BCPS, AEC, below:Derek Webb on LinkedInDennis Williams on LinkedInDennis Williams Faculty Page - UNC Eshelman Schoo...
17 Helmi 25min
S2 Ep70: Global Lessons From FIP: How Pharmacists Can Elevate OTC Allergy Care
You can find more information about Derek Webb, PharmD, and Dennis Williams, PharmD, BCPS, AEC, below:Derek Webb on LinkedInDennis Williams on LinkedInDennis Williams Faculty Page - UNC Eshelman Schoo...
13 Helmi 18min
S2 Ep69: Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
6 Helmi 39min
S2 Ep68: From Underdiagnosed to Under Control: Plozasiran and Pharmacists’ Role in FCS
On Chen, MD, and Tahmid Rahman, MD discuss how plozasiran—an RNA-based APOC3-targeting therapy for patients with familial chylomicronemia syndrome with infrequent injections and a favorable safety pro...
30 Tammi 22min
